EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Folate and cobalamin status, indicators, modulators, interactions, and reference ranges from early pregnancy until birth: the Reus–Tarragona birth cohort study

Luis A Santos-Calderón, Pere Cavallé-Busquets, Carla Ramos-Rodríguez, Carme Grifoll, Alejandra Rojas-Gómez, Mónica Ballesteros, Per M Ueland, Michelle M Murphy

The American Journal of Clinical Nutrition · 2024

DOI: 10.1016/j.ajcnut.2024.09.015 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The American Journal of Clinical Nutrition, 2024. Verfasst von Luis A Santos-Calderón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Preventive Medicine & Biostatistics, Faculty of Medicine & Health Sciences, Universitat Rovira i Virgili (URV), Reus, Spain. Hauptthemen laut MEDLINE: Dietary Supplements, Folic Acid, Homocysteine, Methylenetetrahydrofolate Reductase (NADPH2). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biomedical Research Network Center of the Pathophysiology of Obesity and Nutrition, Italfarmaco, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Folate and cobalamin status, although essential for pregnancy, are not routinely monitored in prenatal care. OBJECTIVES: To investigate folate and cobalamin status and determinants throughout pregnancy, in the absence of mandatory folic acid (FA) fortification. METHODS: In a cohort study of 831 mothers recruited at T genotype. Cobalamin supplementation was positively associated with plasma cobalamin and early holoTC. Smoking and BMI were inversely associated with plasma cobalamin and early holoTC, but none were associated with MMA. Only participants with the MTHFR 677TT genotype, exceeding FA supplement recommendations, improved their folate status (interaction term: B (95% CI):0.15 (0.01, 0.29), P = 0.032). Smoking was inversely associated with plasma cobalamin status in participants with the methionine synthase reductase (MTRR) 524CC genotype only (interaction term:0.07 (0.01, 0.04), P = 0.014). Mothers with low early pregnancy cobalamin status and also those with bigger newborns, had lower cobalamin status at labor. CONCLUSIONS: Suboptimal early pregnancy folate or cobalamin status affected 47.4% and 7.3% of the participants, respectively. The MTHFR 677TT genotype predicted folate status throughout pregnancy. Smoking and BMI were negatively associated with cobalamin status throughout pregnancy. Clinical Trial Registry number and website where it was obtained: NCT01778205. www. CLINICALTRIALS: gov.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsFolic AcidHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)Methylmalonic AcidNutritional StatusPolymorphism, Single NucleotideVitamin B 12AdultFemaleHumansInfant, NewbornPregnancyYoung AdultBirth CohortCohort StudiesReference ValuesTranscobalaminsFerredoxin-NADP Reductase

Stichwörter der Autor:innen

cobalamincordfolateholotranscobalaminhomocysteinemethylmalonic acidpregnancy

Substanzen

Folic AcidHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)Methylmalonic AcidTranscobalaminsVitamin B 12methionine synthase reductaseFerredoxin-NADP ReductaseMTHFR protein, human

Autor:innen und Institutionen

  • Unit of Preventive Medicine & Biostatistics, Faculty of Medicine & Health Sciences, Universitat Rovira i Virgili (URV), Reus, Spain.
  • Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain; Unit of Obstetrics & Gynecology, University Hospital Sant Joan, Reus, Spain; CIBERObn ISCIII, Madrid, Spain.
  • Unit of Preventive Medicine & Biostatistics, Faculty of Medicine & Health Sciences, Universitat Rovira i Virgili (URV), Reus, Spain; Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.
  • Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain; Unit of Obstetrics & Gynecology, University Hospital Sant Joan, Reus, Spain.
  • Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain; Unit of Obstetrics & Gynecology, University Hospital Joan XXIII, Tarragona, Spain.
  • Bevital A/S, Bergen, Norway.

Förderung

  • Biomedical Research Network Center of the Pathophysiology of Obesity and Nutrition
  • Italfarmaco
  • Carlos III Health Institute
  • Pere Virgili Health Research Institute
  • Comisión Interministerial de Ciencia y Tecnología
  • Government of Catalonia Agency for Administration of University and Research Grants
  • State Agency of Research

Zitieren

APA

Santos-Calderón, L. A., Cavallé-Busquets, P., Ramos-Rodríguez, C., Grifoll, C., Rojas-Gómez, A., Ballesteros, M., Ueland, P. M., & Murphy, M. M. (2024). Folate and cobalamin status, indicators, modulators, interactions, and reference ranges from early pregnancy until birth: the Reus–Tarragona birth cohort study. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2024.09.015

Vancouver

Santos-Calderón LA, Cavallé-Busquets P, Ramos-Rodríguez C, Grifoll C, Rojas-Gómez A, Ballesteros M, et al. Folate and cobalamin status, indicators, modulators, interactions, and reference ranges from early pregnancy until birth: the Reus–Tarragona birth cohort study. The American Journal of Clinical Nutrition. 2024. doi:10.1016/j.ajcnut.2024.09.015

BibTeX
@article{SantosCaldern2024,
  author = {Santos-Calderón, Luis A and Cavallé-Busquets, Pere and Ramos-Rodríguez, Carla and Grifoll, Carme and Rojas-Gómez, Alejandra and Ballesteros, Mónica and Ueland, Per M and Murphy, Michelle M},
  title = {Folate and cobalamin status, indicators, modulators, interactions, and reference ranges from early pregnancy until birth: the Reus–Tarragona birth cohort study},
  journal = {The American Journal of Clinical Nutrition},
  year = {2024},
  doi = {10.1016/j.ajcnut.2024.09.015}
}
Kostenlos starten →